Why the study?
Does the VILDIA score improve the prediction of long-term cardiovascular mortality in diabetic patients compared to the established UKPDS risk engine?
Does the VILDIA score improve the prediction of long-term cardiovascular mortality in diabetic patients compared to the established UKPDS risk engine?
The VILDIA score, which incorporates traditional risk factors and novel biomarkers like NT-proBNP and 25-OH vitamin D3, significantly improves the prediction of long-term cardiovascular mortality in patients with diabetes compared to the established UKPDS risk engine.
May improve cardiovascular risk stratification in diabetes by incorporating novel biomarkers; leaves open whether this 22%.
Cardiovascular risk assessment in patients with diabetes relies on traditional risk factors. However, numerous novel biomarkers have been found to be independent predictors of cardiovascular disease, which might significantly improve risk prediction in diabetic patients. We aimed to improve prediction of cardiovascular risk in diabetic patients by investigating 135 evolving biomarkers. Based on selected biomarkers a clinically applicable prediction algorithm for long-term cardiovascular mortality was designed. We prospectively enrolled 864 diabetic patients of the LUdwigshafen RIsk and Cardiovascular health (LURIC) study with a median follow-up of 9.6 years. Independent risk factors were selected using bootstrapping based on a Cox regression analysis. The following seven variables were selected for the final multivariate model: NT-proBNP, age, male sex, renin, diabetes duration, Lp-PLA2 and 25-OH vitamin D3. The risk score based on the aforementioned variables demonstrated an excellent discriminatory power for 10-year cardiovascular survival with a C-statistic of 0.76 (P < 0.001), which was significantly better than the established UKPDS risk engine (C-statistic = 0.64, P < 0.001). Net reclassification confirmed a significant improvement of individual risk prediction by 22% (95% confidence interval: 14-30%) compared to the UKPDS risk engine (P < 0.001). The VILDIA score based on traditional cardiovascular risk factors and reinforced with novel biomarkers outperforms previous risk algorithms.
No takes yet. Share an insight, caveat, or question.
Goliasch et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: